This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Hoffmann-La Roche Inc., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2016.
Company Filing History:
1 out of 5,016 
1 out of 910 
Years Active: 2016
Title: Uri Ben-David: Innovator in Cytotoxic Inhibitors
Introduction
Uri Ben-David is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of selective inhibitors for undifferentiated cells. His work has implications for various medical applications, including cancer treatment.
Latest Patents
Uri Ben-David holds 1 patent for his invention titled "Selective inhibitors of undifferentiated cells." This patent discloses the uses of a compound of any of Formulas I-VI as a cytotoxic inhibitor of undifferentiated cells. It also includes pharmaceutical compositions comprising these compounds and methods for identifying lead candidates for inhibiting undifferentiated cells. Additionally, the patent discusses the use of an SCD-1 inhibitor as a cytotoxic agent against undifferentiated cells.
Career Highlights
Throughout his career, Uri has worked with prominent organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Hoffmann-La Roche Inc. His experience in these companies has allowed him to advance his research and contribute to the scientific community.
Collaborations
Uri has collaborated with esteemed colleagues such as Nissim Benvenisty and Payal Arora. These partnerships have enriched his research and expanded the impact of his work in the field.
Conclusion
Uri Ben-David is a distinguished inventor whose work on selective inhibitors of undifferentiated cells showcases his innovative spirit and dedication to advancing medical science. His contributions are paving the way for future breakthroughs in biotechnology.